Review article: COVID-19 and liver disease-what we know on 1st May 2020.

Isabel GarridoRodrigo LiberalGuilherme Macedo

Published in: Alimentary pharmacology & therapeutics (2020)

Abnormal liver function tests during the course of COVID-19 are common, though clinically significant liver injury is rare. Further research is needed focusing on the effect of existing liver-related comorbidities on treatment and outcome of COVID-19.

Keyphrases

coronavirus disease
sars cov
liver injury
drug induced
respiratory syndrome coronavirus